Cor Vasa 2017, 59(5):e430-e435

Rapidly progressive heart failure in a patient with restrictive cardiomyopathy secondary to newly diagnosed multiple myeloma

Zuzana Jadvišová*, Jiří Knot, Zuzana Moťovská
III. interní-kardiologická klinika, Kardiocentrum, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha, Česká republika

Restrictive cardiomyopathy is a rare disease of the myocardium characterized by elevated filling pressures, limited left ventricular filling with usually normal systolic function. The most common cause in our geographic region is AL amyloidosis. This paper describes the case of a patient in whom multiple myeloma was diagnosed in an advanced stage of the disease, with organ damage and progressive heart failure, which was gradually reducing the quality of life and which despite the initiation of intensive treatment led to a patient's death.
This case proves that the disease gets little attention, is diagnosed late, and therefore it is important to remind this diagnosis. Early detection of the etiology of heart failure has a significant impact on the effectivity and success of treatment.

Keywords: AL amyloidosis; Heart failure; Multiple myeloma; Restrictive cardiomyopathy

Received: July 25, 2016; Revised: September 6, 2016; Accepted: September 15, 2016; Published: October 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jadvišová Z, Knot J, Moťovská Z. Rapidly progressive heart failure in a patient with restrictive cardiomyopathy secondary to newly diagnosed multiple myeloma. Cor Vasa. 2017;59(5):e430-435.
Download citation

References

  1. P. Nihoyannopoulos, D. Dawson, Restrictive cardiomyopathies, European Journal of Echocardiography 10 (2009) iii23-iii33. Go to original source...
  2. J.D. Sipe, M.D. Benson, J.N. Buxbaum, et al., Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis, Amyloid 21 (4) (2014) 221-224. Go to original source... Go to PubMed...
  3. J. Krejčí, Heart failure in AL amyloidosis - are we still helpless?, Cor et Vasa 55 (2013) e330-e332. Go to original source...
  4. J.D. Gillmore, A. Wechalekar, J. Bird, et al., on behalf of the BCSH Committee, Guidelines on the diagnosis and investigation of AL amyloidosis, British Journal of Haematology 168 (2015) 207-218. Go to original source... Go to PubMed...
  5. M. Kubánek, Kardiomyopatie a myokarditidy, in: J. Kautzner, V. Melenovský, et al. (Eds.), Srdeční selhání. Aktuality pro klinickou praxi, Praha: Mladá fronta, 2015: 139-143.
  6. Z. Adam, M. Krejčí, J. Simonides, Choroby způsobené ukládáním monoklonálních imunoglobulinů, Postgraduální medicína 9 (2011) 1009-1017.
  7. B. Murtagh, S.C. Hamill, M.A. Gertz, et al., Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement, American Journal of Cardiology 95 (2005) 535-537. Go to original source... Go to PubMed...
  8. S.M. Banypersad, J.C. Moon, C. Whelan, et al., Updates in cardiac amyloidosis: a review, Journal of the American Heart Association 1 (2012) e000364. Go to original source... Go to PubMed...
  9. M.J. Garcia, Constrictive pericarditis versus restrictive cardiomyopathy?, Journal of the American College of Cardiology 67 (2016) 2061-2076. Go to original source... Go to PubMed...
  10. W. Hassan, H. Al-Sergani, W. Mourad, R. Tabbaa, Amyloid heart disease, new frontiers and insights in pathophysiology, diagnosis and management, Texas Heart Institute Journal 32 (2005) 178-184. Go to PubMed...
  11. S. Mahmood, G. Palladini, V. Sanchorawala, A. Wechalekar, Update on treatment of light chain amyloidosis, Haematologica 99 (2014) 209-221. Go to original source... Go to PubMed...
  12. R.H. Sayed, D. Rogers, F. Khan, et al., A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis, European Heart Journal 36 (2015) 1098-1105. Go to original source... Go to PubMed...
  13. V.L. Roger, Heart failure compendium, epidemiology of heart failure, Circulation Research 113 (2013) 646-659. Go to original source... Go to PubMed...
  14. Restrictive Cardiomyopathy, 2014, available at: http://emedicine.medscape.com/article/153062-overview [online; cited 05.07.16].
  15. V. Brahmanandam, S. McGraw, O. Mirza, et al., Regression of cardiac amyloidosis after stem cell transplantation assessed by cardiovascular magnetic resonance imaging, Circulation 129 (2014) 2326-2328. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.